Diagnosis and Treatment of Lung Lesions (NCT07642986) | Clinical Trial Compass
CompletedNot Applicable
Diagnosis and Treatment of Lung Lesions
China25 participantsStarted 2024-05-01
Plain-language summary
To evaluate the safety and feasibility of a single-session "diagnose and treat" (one-stop) paradigm utilizing robotic-assisted bronchoscopy (RAB).
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
. Age ≥18 years.
. Have peripheral pulmonary lesions (PPLs).
. Meet at least one of the following conditions: (1) Deemed medically inoperable due to surgical intolerance; (2) Have newly developed or residual nodules after previous lung cancer surgery; (3) Present with multiple bilateral pulmonary nodules; or (4) Explicitly refuse surgical resection.
Exclusion criteria
. Centrally located tumors invading the main bronchi.
. Uncorrectable coagulopathy.
. Evidence of advanced nodal (N2/N3) or distant metastatic disease (unless the PPL represented an oligometastatic lesion targeted with curative intent).
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Since this trial has already been completed, would you be able to share or look up any published results showing how often the navigation and ablation procedures actually succeeded in reaching and treating peripheral lung nodules?
2This trial measured post-operative complication rates — what kinds of complications were observed, and how do they compare to the risks of other approaches like surgery or standard bronchoscopy for treating lung nodules like mine?
3The trial focused on navigation success and ablation success as separate outcomes — what does it mean in practice if navigation succeeds but ablation does not, and what would happen next in that scenario?
4Given that this trial is now completed and listed as 'Phase NA,' meaning it was likely evaluating a technique or device rather than a drug, is the navigation-guided ablation approach used in this study something that's available to me now as a standard treatment option?
5Would you recommend this ablation approach for my specific nodule — given its size and location — or is surgical removal or active surveillance still a better first step for my situation?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Navigation success rate
Timeframe: Perioperatively
2
Ablation success rate
Timeframe: Perioperatively
3
Post-operative complication rate
Timeframe: Immediately after the procedure through hospital discharge